Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés A, Paz-Y-Miño C, Guerrero S, Jaramillo-Koupermann G, León Cáceres Á, Intriago-Baldeón DP, García-Cárdenas JM, Guevara-Ramírez P, Armendáriz-Castillo I, Leone PE, Quiñones LA, Cayún JP, Soria NW. López-Cortés A, et al. Among authors: cayun jp. Pharmacogenomics J. 2020 Feb;20(1):136-158. doi: 10.1038/s41397-019-0102-4. Epub 2019 Oct 15. Pharmacogenomics J. 2020. PMID: 31616044 Review.
Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
Quinones LA, Lavanderos MA, Cayun JP, Garcia-Martin E, Agundez JA, Caceres DD, Roco AM, Morales JE, Herrera L, Encina G, Isaza CA, Redal MA, Larovere L, Soria NW, Eslava-Schmalbach J, Castaneda-Hernandez G, Lopez-Cortes A, Magno LA, Lopez M, Chiurillo MA, Rodeiro I, Castro de Guerra D, Teran E, Estevez-Carrizo F, Lares-Assef I. Quinones LA, et al. Among authors: cayun jp. Curr Drug Metab. 2014 Feb;15(2):202-8. doi: 10.2174/1389200215666140202220753. Curr Drug Metab. 2014. PMID: 24524664
Clinical applications of pharmacogenomics.
Quiñones L, Roco Á, Cayún JP, Escalante P, Miranda C, Varela N, Meneses F, Gallegos B, Zaruma-Torres F, Lares-Asseff I. Quiñones L, et al. Among authors: cayun jp. Rev Med Chil. 2017 Apr;145(4):483-500. doi: 10.4067/S0034-98872017000400009. Rev Med Chil. 2017. PMID: 28748996 Free article. Review.
[Pharmacogenetics, tobacco, alcohol and its effect on the risk development cancer].
Roco Á, Cerda B, Cayún JP, Lavanderos A, Rubilar JC, Cerro R, Acevedo C, Cáceres D, Varela N, Quiñones LA. Roco Á, et al. Among authors: cayun jp. Rev Chil Pediatr. 2018 Aug;89(4):432-440. doi: 10.4067/S0370-41062018005000709. Rev Chil Pediatr. 2018. PMID: 30571815 Free article. Review. Spanish.
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
Lavanderos MA, Cayún JP, Roco Á, Sandoval C, Cerpa L, Rubilar JC, Cerro R, Molina-Mellico S, Celedón C, Cerda B, García-Martín E, Agúndez JAG, Acevedo C, Peña K, Cáceres DD, Varela NM, Quiñones LA. Lavanderos MA, et al. Among authors: cayun jp. Front Pharmacol. 2019 Mar 8;10:206. doi: 10.3389/fphar.2019.00206. eCollection 2019. Front Pharmacol. 2019. PMID: 30914949 Free PMC article.
The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer.
Roco A, Lavanderos A, Cayún JP, Acevedo C, Celedón C, Rubilar JC, Sandoval C, Cerpa L, García-Martín E, Agúndez JA, Esguevillas G, Amo G, Canepa A, Cerda B, Peña K, Cáceres DD, Varela NM, Quiñones LA. Roco A, et al. Among authors: cayun jp. Pharmacogenet Genomics. 2019 Sep;29(7):159-166. doi: 10.1097/FPC.0000000000000379. Pharmacogenet Genomics. 2019. PMID: 31107374
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Salas-Hernández A, Galleguillos M, Carrasco M, López-Cortés A, Redal MA, Fonseca-Mendoza D, Esperón P, González-Martínez F, Lares-Asseff I, Lazarowski A, Loera-Castañeda V, Remírez D, Martínez MF, Vargas R, Rios-Santos F, Macho A, Cayún JP, Perez GR, Gutierrez C, Cerpa LC, Leiva T, Calfunao S, Xajil L, Sandoval C, Suárez M, Gonzalez A, Echeverría-Garcés G, Sullón-Dextre L, Cordero-García E, Morales AR, Avendaño A, Sánchez E, Bastone LC, Lara C, Zuluaga-Arias P, Soler AM, Da Luz J, Burgueño-Rodríguez G, Vital M, Reyes-Reyes E, Huaccha A, Ariza YV, Tzul N, Rendón AL, Serrano R, Acosta L, Motta-Pardo A, Beltrán-Angarita L, Brand E, Jiménez MA, Hidalgo-Lozada GM, Romero-Prado MMJ, Escobar-Castro K, Umaña-Rivas M, Vivas JD, Lagos P, Martínez YB, Quesada S, Calfio C, Arias ML, Lavanderos MA, Cáceres DD, Salazar-Granara A, Varela NM, Quiñones LA. Salas-Hernández A, et al. Among authors: cayun jp. Front Pharmacol. 2023 May 11;14:1175737. doi: 10.3389/fphar.2023.1175737. eCollection 2023. Front Pharmacol. 2023. PMID: 37251329 Free PMC article.
Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients.
Contreras-Castillo S, Plaza A, Stojanova J, Navarro G, Carmona R, Corvalán F, Cerpa L, Sandoval C, Muñoz D, Leiva M, Castañeda LE, Farias N, Alvarez C, Llull G, Mezzano S, Ardiles L, Varela N, Rodríguez MS, Flores C, Cayún JP, Krall P, Quiñones LA. Contreras-Castillo S, et al. Among authors: cayun jp. Front Pharmacol. 2021 Dec 6;12:674117. doi: 10.3389/fphar.2021.674117. eCollection 2021. Front Pharmacol. 2021. PMID: 34938174 Free PMC article.
11 results